Obesity in United Arab Emirates

From WikiMD's WELLNESSPEDIA


The United Arab Emirates (UAE), a country located in the Middle East, had an adult obesity rate of 31.7% in 2016, ranking it 20th globally. This high rate of obesity is a significant public health concern, as it is associated with numerous health problems including diabetes, heart disease, and certain types of cancer.

Obesity in the United Arab Emirates[edit]

The prevalence of obesity in the UAE is a result of a combination of factors including a sedentary lifestyle, unhealthy dietary habits, and genetic predisposition. The rapid economic development in the UAE over the past few decades has led to significant changes in lifestyle, with an increase in sedentary behavior and consumption of high-calorie, low-nutrient foods.

Healthcare Facilities for Weight Loss[edit]

Several healthcare facilities in the UAE offer weight loss programs and treatments. These include:

  • Zulekha Hospital: This hospital offers a comprehensive weight loss program that includes dietary counseling, physical activity guidance, and surgical options if necessary.
  • Cleveland Clinic Abu Dhabi: This clinic provides a multidisciplinary approach to weight loss, with a team of dietitians, exercise physiologists, and bariatric surgeons.
  • American Hospital Dubai: This hospital offers a Bariatric and Metabolic Surgery program, which includes surgical weight loss options for individuals with severe obesity.

See Also[edit]

the World
Countries
Afghanistan / Albania / Algeria / Andorra / Angola / Antigua and Barbuda / Argentina / Armenia / Australia / Austria / Azerbaijan / Bahamas / Bahrain / Bangladesh / Barbados / Belarus / Belgium / Belize / Benin / Bhutan / Bolivia / Bosnia and Herzegovina / Botswana / Brazil / Brunei / Bulgaria / Burkina Faso / Burundi / Cambodia / Cameroon / Canada / Cape Verde / Central African Republic / Chad / Chile / China / Colombia / Comoros / Costa Rica / Croatia / Cuba / Cyprus / Czech Republic / Democratic Republic of the Congo / Denmark / Djibouti / Dominica / Dominican Republic / Ecuador / Egypt / El Salvador / Equatorial Guinea / Eritrea / Estonia / Eswatini / Ethiopia / Federated States of Micronesia / Fiji / Finland / France / Gabon / Gambia / Georgia / Germany / Ghana / Greece / Grenada / Guatemala / Guinea / Guinea-Bissau / Guyana / Haiti / Honduras / Hungary / Iceland / India / Indonesia / Iran / Iraq / Ireland / Israel / Italy / Ivory Coast / Jamaica / Japan / Jordan / Kazakhstan / Kenya / Kiribati / Kosovo / Kuwait / Kyrgyzstan / Laos / Latvia / Lebanon / Lesotho / Liberia / Libya / Liechtenstein / Lithuania / Luxembourg / Madagascar / Malawi / Malaysia / Maldives / Mali / Malta / Marshall Islands / Mauritania / Mauritius / Mexico / Moldova / Monaco / Mongolia / Montenegro / Morocco / Mozambique / Myanmar / Namibia / Nauru / Nepal / Netherlands / New Zealand / Nicaragua / Niger / Nigeria / North Korea / North Macedonia / Norway / Oman / Pakistan / Palau / Palestine / Panama / Papua New Guinea / Paraguay / Peru / Philippines / Poland / Portugal / Qatar / Republic of the Congo / Romania / Russia / Rwanda / Saint Kitts and Nevis / Saint Lucia / Saint Vincent and the Grenadines / Samoa / San Marino / Saudi Arabia / Senegal / Serbia / Seychelles / Sierra Leone / Singapore / Slovakia / Slovenia / Solomon Islands / Somalia / South Africa / South Korea / South Sudan / Spain / Sri Lanka / Sudan / Suriname / Sweden / Switzerland / Syria / São Tomé and Príncipe / Taiwan / Tajikistan / Tanzania / Thailand / Timor-Leste / Togo / Tonga / Trinidad and Tobago / Tunisia / Turkey / Turkmenistan / Tuvalu / Uganda / Ukraine / United Arab Emirates / United Kingdom / United States / Uruguay / Uzbekistan / Vanuatu / Vatican City / Venezuela / Vietnam / Western Sahara / Yemen / Zambia / Zimbabwe


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Obesity_in_United_Arab_Emirates&oldid=6529005"